carvedilol and sb 203580

carvedilol has been researched along with sb 203580 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dun, Y; Sun, HY; Zhao, RR; Zhao, ZQ; Zhi, JM1
Altieri, P; Ballestrero, A; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Spallarossa, P1

Other Studies

2 other study(ies) available for carvedilol and sb 203580

ArticleYear
Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.
    Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:7

    Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Carbazoles; Carvedilol; Cells, Cultured; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Imidazoles; In Situ Nick-End Labeling; Microscopy, Electron; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Neutrophils; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Propanolamines; Pyridines; Rats; Signal Transduction

2002
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.
    Cardiovascular research, 2006, Feb-15, Volume: 69, Issue:3

    Topics: Anthracenes; Antibiotics, Antineoplastic; Antioxidants; Blotting, Western; Carbazoles; Carvedilol; Catecholamines; Cell Line; Doxorubicin; Enzyme Activation; Flavonoids; Humans; Imidazoles; Imidazolines; Janus Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein-Tyrosine Kinases; Pyridines; Razoxane

2006